Correlation Between Grifols SA and AstraZeneca PLC

Can any of the company-specific risk be diversified away by investing in both Grifols SA and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grifols SA and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Grifols SA ADR and AstraZeneca PLC, you can compare the effects of market volatilities on Grifols SA and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grifols SA with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grifols SA and AstraZeneca PLC.

Diversification Opportunities for Grifols SA and AstraZeneca PLC

0.48

Correlation Coefficient

Grifols SA  AstraZeneca PLC

Very weak diversification

The 3 months correlation between Grifols and AstraZeneca is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Grifols SA ADR and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and Grifols SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grifols SA ADR are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of Grifols SA i.e., Grifols SA and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Grifols SA and AstraZeneca PLC

Given the investment horizon of 90 days Grifols SA ADR is expected to under-perform the AstraZeneca PLC. But the stock apears to be less risky and, when comparing its historical volatility, Grifols SA ADR is 1.09 times less risky than AstraZeneca PLC. The stock trades about 0.0 of its potential returns per unit of risk. The AstraZeneca PLC is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  13,000  in AstraZeneca PLC on December 31, 2024 and sell it today you would earn a total of  1,747  from holding AstraZeneca PLC or generate 13.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Grifols SA ADR  vs.  AstraZeneca PLC

Grifols SA ADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days Grifols SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Grifols SA is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

AstraZeneca PLC

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, AstraZeneca PLC reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Grifols SA and AstraZeneca PLC

The main advantage of trading using opposite Grifols SA and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grifols SA position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.

The idea behind Grifols SA ADR and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.